Capital Group Global Equity Fund (LUX) CgdRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 16.1 | -4.7 | 12.4 | 9.0 | |
+/-Cat | - | -2.0 | 4.6 | -0.4 | -0.7 | |
+/-B’mrk | - | -3.6 | 3.0 | -2.8 | -3.7 | |
Category: Global Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar Global TME NR USD |
Key Stats | ||
NAV 25/10/2024 | EUR 56.20 | |
Day Change | 0.22% | |
Morningstar Category™ | Global Large-Cap Blend Equity | |
ISIN | LU2227286494 | |
Fund Size (Mil) 25/10/2024 | USD 665.48 | |
Share Class Size (Mil) 25/10/2024 | EUR 1.90 | |
Max Initial Charge | - | |
Ongoing Charge 15/08/2024 | 0.12% |
Investment Objective: Capital Group Global Equity Fund (LUX) Cgd |
Long-term capital growth through investment primarily in listed Equity, researched and selected on a world-wide basis. Unlisted securities may also be purchased, subject to the relevant provisions of the "General Investment Guidelines and Restrictions". |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Philip Winston 22/01/2020 | ||
William Robbins 22/01/2020 | ||
Click here to see others | ||
Inception Date 16/10/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR USD | Morningstar Global TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Capital Group Global Equity Fund (LUX) Cgd | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Broadcom Inc | Technology | 2.75 |
Novo Nordisk AS Class B | Healthcare | 2.52 |
Microsoft Corp | Technology | 2.33 |
Apple Inc | Technology | 2.15 |
AstraZeneca PLC | Healthcare | 2.04 |
Increase Decrease New since last portfolio | ||
Capital Group Global Equity Fund (LUX) Cgd |